M&A
By bringing both companies' online reputation management tools in-house, Press Ganey aims to combine patient feedback and online acquisition into a single digital platform.
Also: Livongo leverages Teladoc Health's connections for new business with Florida Blue; Amwell and Tyto Care reinforce partnership with "exclusive integrations."
The marriage of Teladoc Health and Livongo stood out amidst a quarter with relatively few M&A deals.
The acquisition deal is worth $300 million, per CNBC.
The deal joins each company's voice sample datasets to improve R&D, and helps Sonde collect more data across platforms.
Digital Diagnostics, formerly IDx, is looking to expand into the skin health space with this new purchase.
Also: Centauri Health Solutions acquires HCFS; UCSF researchers detail smartphone PPG-based diabetes detection.
The patient-facing EASE app is HIPAA compliant, and does not save any texts, photos or videos to the recipient's device.
The company's smart insulin pen, dubbed the InPen, is slated to become part of Medtronics diabetes portfolio.
Each Livongo share will be converted Teladoc stock at a 0.5920 exchange rate, plus an additional $11.44 in cash per stock.